This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.00459-07v1 81/15/8072    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Falkowska, E. Articles by Dragic, T. Search for Related Content PubMed PubMed Citation Articles by Falkowska, E. Articles by Dragic, T.

 Previous Article  |  Next Article 

Journal of Virology, August 2007, p. 8072-8079, Vol. 81, No. 15
0022-538X/07/$08.00+0     doi:10.1128/JVI.00459-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York,¹ Progenics Pharmaceuticals, Inc., Tarrytown, New York,² Division of Gastroenterology and Hepatology, Montefiore Medical Center, Bronx, New York³

Received 3 March 2007/ Accepted 9 May 2007

Hepatitis C virus (HCV) is a major human pathogen that causes serious liver disease, including cirrhosis and hepatocellular carcinoma. The primary target cells of HCV are hepatocytes, and entry is restricted by interactions of the envelope glycoproteins, E1 and E2, with cellular receptors. E1 and E2 form noncovalently linked heterodimers and are heavily glycosylated. Glycans contribute to protein folding and transport as well as protein function. In addition, glycans associated with viral envelopes mask important functional domains from the immune system and attenuate viral immunogenicity. Here, we explored the role of N- and O-linked glycans on E2, which is the receptor binding subunit of the HCV envelope. We identified a number of glycans that are critical for viral entry. Importantly, we showed that the removal of several glycans significantly increased the inhibition of entry by sera from HCV-positive individuals. Only some of the glycans that affected entry and neutralization were also important for CD81 binding. Our results show that HCV envelope-associated glycans play a crucial role in masking functionally important regions of E2 and suggest a new strategy for eliciting highly neutralizing antibodies against this virus.

Published ahead of print on 16 May 2007.

This article has been cited by other articles:

• Fenouillet, E., Lavillette, D., Loureiro, S., Krashias, G., Maurin, G., Cosset, F.-L., Jones, I. M., Barbouche, R. (2008). Contribution of Redox Status to Hepatitis C Virus E2 Envelope Protein Function and Antigenicity. J. Biol. Chem. 283: 26340-26348 [Abstract] [Full Text]  
• Keck, Z.-Y., Li, T.-K., Xia, J., Gal-Tanamy, M., Olson, O., Li, S. H., Patel, A. H., Ball, J. K., Lemon, S. M., Foung, S. K. H. (2008). Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies. J. Virol. 82: 6061-6066 [Abstract] [Full Text]  
• Russell, R. S., Meunier, J.-C., Takikawa, S., Faulk, K., Engle, R. E., Bukh, J., Purcell, R. H., Emerson, S. U. (2008). Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc. Natl. Acad. Sci. USA 105: 4370-4375 [Abstract] [Full Text]